AbCellera Biologics (ABCL) Q3 2024 Earnings

6AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.16
-0.14
-0.12
-0.1

Details

Expected EPS
-0.12
Actual EPS
-0.13
Surprise EPS
-0.01
Surprise Percent
+8.33%

Description

AbCellera Biologics (ABCL) has reported earnings of -0.13 per share for Q3 2024.

0 Comments

Share your thoughts